
China has introduced GMP inspection guidelines for sterile, implantable, IVD, custom-made denture and standalone software medical devices.

India’s CDSCO releases final medical device software guidance under MDR 2017, outlining licensing routes, software risk classes, and cybersecurity standards.

Taiwan's TFDA has revised its processing time limits table for public applications, adding eight application items and amending two existing items.

Updated MDACS guidance creates a new pathway for qualifying technologies and outlines the evidence required for priority consideration.

The new documents clarify expectations for Tier III variants, companion diagnostic clinical evaluation, tissue and plasma registration, and HLA-B*58:01 analytical validation.

New WHO CRP pathway enables faster MDA review of eligible WHO-prequalified IVDs.

New policy streamlines COVID-19 Antigen RDT registration and renewal applications.

Summary of 2025 MFDS trends covering medical device approvals, import dynamics, and the shift toward AI and software-based regulation.

China’s National Medical Products Administration has issued its 2026 medical device standards plan, introducing 80+ new and revised standards

Learn about the 104 products China’s NMPA admitted into the Special Review Procedure for Innovative Medical Devices in 2025.

Hong Kong’s Department of Health introduces Pre-NDA meetings to streamline new drug registrations under the “1+” mechanism.

The Department of Health has mandated MDACS listing for public procurement eligibility — see which devices are affected and how to prepare.
And discover how we can support you in getting your products certified for China.